Impel Neuropharma Inc reports results for the quarter ended in June - Earnings Summary

IPI Legacy Liquidation Co

16/08/2021 14:21

* Impel Neuropharma Inc  IMPL.OQ  reported a quarterly adjusted
loss of $1.10​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 60 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Impel Neuropharma Inc's reported EPS for the quarter was a
loss of $1.10​.
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Impel Neuropharma Inc shares had risen by 61.0% this quarter.
* The company reported a quarterly loss of $15.48 million.
* Wall Street's median 12-month price target for Impel
Neuropharma Inc is $32.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 16 at 01:21 p.m.  ​All
figures in US dollars unless otherwise stated